{"studyId":"prad_pik3r1_msk_2021","cancerTypeId":"prad","name":"Prostate Adenocarcinoma (MSK, Clin Cancer Res. 2022)","description":"Targeted sequencing of 1417 Prostate Adenocarcinoma tumor/normal sample pairs via MSK-IMPACT to analyze the significance of PIK3R1 alterations.","publicStudy":true,"pmid":"35670774","citation":"Chakraborty et al. Clin Cancer Research 2022","groups":"","status":1,"importDate":"2026-01-16 16:39:55","allSampleCount":1417,"sequencedSampleCount":1417,"cnaSampleCount":1417,"mrnaRnaSeqSampleCount":0,"mrnaRnaSeqV2SampleCount":0,"mrnaMicroarraySampleCount":0,"miRnaSampleCount":0,"methylationHm27SampleCount":0,"rppaSampleCount":0,"massSpectrometrySampleCount":0,"completeSampleCount":0,"referenceGenome":"hg19","treatmentCount":0,"structuralVariantCount":697,"cancerType":{"id":"prad","name":"Prostate Adenocarcinoma","dedicatedColor":"Cyan","shortName":"PRAD","parent":"prostate"},"readPermission":true,"resourceCounts":[]}